GLP-1RA and SGLT2 Inhibitor Prescribing in People With Diabetes

This pooled cross-sectional study explores prescribing rates for glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors among US patients with type 1 diabetes.